166 related articles for article (PubMed ID: 29755980)
21. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
[TBL] [Abstract][Full Text] [Related]
22. shRNA kinome screen identifies TBK1 as a therapeutic target for HER2+ breast cancer.
Deng T; Liu JC; Chung PE; Uehling D; Aman A; Joseph B; Ketela T; Jiang Z; Schachter NF; Rottapel R; Egan SE; Al-Awar R; Moffat J; Zacksenhaus E
Cancer Res; 2014 Apr; 74(7):2119-30. PubMed ID: 24487029
[TBL] [Abstract][Full Text] [Related]
23. TANK-binding kinase 1 (TBK1) modulates inflammatory hyperalgesia by regulating MAP kinases and NF-κB dependent genes.
Möser CV; Stephan H; Altenrath K; Kynast KL; Russe OQ; Olbrich K; Geisslinger G; Niederberger E
J Neuroinflammation; 2015 May; 12():100. PubMed ID: 25997745
[TBL] [Abstract][Full Text] [Related]
24. Intracellular Phospho-Flow cytometry reveals novel insights into TCR proximal signaling events. A comparison with Western blot.
Haas A; Weckbecker G; Welzenbach K
Cytometry A; 2008 Sep; 73(9):799-807. PubMed ID: 18548611
[TBL] [Abstract][Full Text] [Related]
25. Crosstalk between TBK1/IKKε and the type I interferon pathway contributes to tubulointerstitial inflammation and kidney tubular injury.
Córdoba-David G; García-Giménez J; Cardoso Castelo-Branco R; Carrasco S; Cannata P; Ortiz A; Ramos AM
Front Pharmacol; 2022; 13():987979. PubMed ID: 36386242
[TBL] [Abstract][Full Text] [Related]
26. Encephalomyocarditis virus 3C protease attenuates type I interferon production through disrupting the TANK-TBK1-IKKε-IRF3 complex.
Huang L; Xiong T; Yu H; Zhang Q; Zhang K; Li C; Hu L; Zhang Y; Zhang L; Liu Q; Wang S; He X; Bu Z; Cai X; Cui S; Li J; Weng C
Biochem J; 2017 Jun; 474(12):2051-2065. PubMed ID: 28487378
[TBL] [Abstract][Full Text] [Related]
27. Regulation of c-Jun phosphorylation by the I kappa B kinase-epsilon complex in fibroblast-like synoviocytes.
Sweeney SE; Hammaker D; Boyle DL; Firestein GS
J Immunol; 2005 May; 174(10):6424-30. PubMed ID: 15879144
[TBL] [Abstract][Full Text] [Related]
28. A novel IRAK1-IKKε signaling axis limits the activation of TAK1-IKKβ downstream of TLR3.
Bruni D; Sebastia J; Dunne S; Schröder M; Butler MP
J Immunol; 2013 Mar; 190(6):2844-56. PubMed ID: 23396947
[TBL] [Abstract][Full Text] [Related]
29. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.
Fitzgerald KA; McWhirter SM; Faia KL; Rowe DC; Latz E; Golenbock DT; Coyle AJ; Liao SM; Maniatis T
Nat Immunol; 2003 May; 4(5):491-6. PubMed ID: 12692549
[TBL] [Abstract][Full Text] [Related]
30. PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1.
Xiang W; Zhang Q; Lin X; Wu S; Zhou Y; Meng F; Fan Y; Shen T; Xiao M; Xia Z; Zou J; Feng XH; Xu P
Sci Adv; 2016 Jul; 2(7):e1501889. PubMed ID: 27419230
[TBL] [Abstract][Full Text] [Related]
31. Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKε- and CYLD-dependent Bcl3 activation.
Gringhuis SI; Kaptein TM; Wevers BA; Mesman AW; Geijtenbeek TB
Nat Commun; 2014 May; 5():3898. PubMed ID: 24867235
[TBL] [Abstract][Full Text] [Related]
32. Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer.
Durand JK; Zhang Q; Baldwin AS
Cells; 2018 Sep; 7(9):. PubMed ID: 30223576
[TBL] [Abstract][Full Text] [Related]
33. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
34. Analysis of novel phospho-ITAM specific antibodies in a S2 reconstitution system for TCR-CD3 signalling.
Dopfer EP; Schöpf B; Louis-Dit-Sully C; Dengler E; Höhne K; Klescová A; Prouza M; Suchanek M; Reth M; Schamel WW
Immunol Lett; 2010 May; 130(1-2):43-50. PubMed ID: 20005895
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions.
Kaukinen P; Sillanpää M; Nousiainen L; Melén K; Julkunen I
J Med Virol; 2013 Jan; 85(1):71-82. PubMed ID: 23096996
[TBL] [Abstract][Full Text] [Related]
36. IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex.
Peters RT; Liao SM; Maniatis T
Mol Cell; 2000 Mar; 5(3):513-22. PubMed ID: 10882136
[TBL] [Abstract][Full Text] [Related]
37. Targeting HER2(+) breast cancer: the TBK1/IKKε axis.
Jiang Z; Liu JC; Chung PE; Egan SE; Zacksenhaus E
Oncoscience; 2014; 1(2):180-2. PubMed ID: 25594009
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of DDX3 expression by ginsenoside Rg3 through the Akt/p53 pathway activates the innate immune response via TBK1/IKKε/IRF3 signalling.
Choi YJ; Kang LJ; Lee SG
Curr Med Chem; 2014; 21(8):1050-60. PubMed ID: 24180280
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.
Reiley W; Zhang M; Wu X; Granger E; Sun SC
Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263
[TBL] [Abstract][Full Text] [Related]
40. CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes.
Urbanik T; Koehler BC; Wolpert L; Elßner C; Scherr AL; Longerich T; Kautz N; Welte S; Hövelmeyer N; Jäger D; Waisman A; Schulze-Bergkamen H
World J Gastroenterol; 2014 Dec; 20(45):17049-64. PubMed ID: 25493017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
